Amir Nashat

A picture of condensates against a black background

Biotech

Dewpoint Therapeutics nets $77M in series B round

Dewpoint Therapeutics aims to advance research in one of the more mysterious cell organelles: biomolecular condensates.

Amy Sokolow Sep 29, 2020 6:00am

Bayer, Dewpoint ink $100M heart disease, women's health R&D deal

Nov 14, 2019 7:00am